vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and Fold Holdings, Inc. (FLD). Click either name above to swap in a different company.

Fortress Biotech, Inc. is the larger business by last-quarter revenue ($16.1M vs $9.1M, roughly 1.8× Fold Holdings, Inc.). Fortress Biotech, Inc. runs the higher net margin — -24.5% vs -379.9%, a 355.4% gap on every dollar of revenue. On growth, Fold Holdings, Inc. posted the faster year-over-year revenue change (8.2% vs 6.3%). Over the past eight quarters, Fold Holdings, Inc.'s revenue compounded faster (36.1% CAGR vs 11.0%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Fold Holdings, Inc. is a U.S.-based fintech firm specializing in crypto-integrated consumer financial products. Its core offerings include a rewards debit card that provides Bitcoin and other cryptocurrency cashback on routine purchases, alongside user-friendly digital wallet tools for secure crypto storage, serving primarily the North American consumer market.

FBIO vs FLD — Head-to-Head

Bigger by revenue
FBIO
FBIO
1.8× larger
FBIO
$16.1M
$9.1M
FLD
Growing faster (revenue YoY)
FLD
FLD
+1.9% gap
FLD
8.2%
6.3%
FBIO
Higher net margin
FBIO
FBIO
355.4% more per $
FBIO
-24.5%
-379.9%
FLD
Faster 2-yr revenue CAGR
FLD
FLD
Annualised
FLD
36.1%
11.0%
FBIO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
FLD
FLD
Revenue
$16.1M
$9.1M
Net Profit
$-3.9M
$-34.7M
Gross Margin
66.1%
Operating Margin
-28.8%
-380.0%
Net Margin
-24.5%
-379.9%
Revenue YoY
6.3%
8.2%
Net Profit YoY
41.8%
-7232.4%
EPS (diluted)
$-0.15
$-0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
FLD
FLD
Q4 25
$16.1M
$9.1M
Q3 25
$17.6M
$7.4M
Q2 25
$16.4M
$8.2M
Q1 25
$13.1M
$7.1M
Q4 24
$15.1M
$8.4M
Q3 24
$14.6M
$5.2M
Q2 24
$14.9M
$5.1M
Q1 24
$13.0M
$4.9M
Net Profit
FBIO
FBIO
FLD
FLD
Q4 25
$-3.9M
$-34.7M
Q3 25
$5.8M
$554.2K
Q2 25
$15.5M
$13.4M
Q1 25
$-10.6M
$-48.9M
Q4 24
$-6.8M
$486.4K
Q3 24
$-12.9M
$-62.3M
Q2 24
$-10.9M
$-2.3M
Q1 24
$-15.4M
$-945.0K
Gross Margin
FBIO
FBIO
FLD
FLD
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
FLD
FLD
Q4 25
-28.8%
-380.0%
Q3 25
-38.6%
7.5%
Q2 25
-222.2%
Q1 25
-169.9%
-689.6%
Q4 24
-158.3%
-9.1%
Q3 24
-151.0%
-15.3%
Q2 24
-186.5%
-12.2%
Q1 24
-280.6%
-14.7%
Net Margin
FBIO
FBIO
FLD
FLD
Q4 25
-24.5%
-379.9%
Q3 25
33.2%
7.5%
Q2 25
94.4%
164.2%
Q1 25
-80.6%
-689.6%
Q4 24
-44.7%
5.8%
Q3 24
-88.0%
-1188.7%
Q2 24
-73.5%
-45.1%
Q1 24
-118.3%
-19.2%
EPS (diluted)
FBIO
FBIO
FLD
FLD
Q4 25
$-0.15
$-0.02
Q3 25
$0.11
$0.01
Q2 25
$0.45
$0.28
Q1 25
$-0.48
$-1.92
Q4 24
$-0.16
$0.09
Q3 24
$-0.76
$-10.68
Q2 24
$-0.73
$-0.40
Q1 24
$-1.04
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
FLD
FLD
Cash + ST InvestmentsLiquidity on hand
$79.4M
$7.7M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$63.0M
Total Assets
$185.5M
$153.5M
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
FLD
FLD
Q4 25
$79.4M
$7.7M
Q3 25
$86.2M
$6.7M
Q2 25
$74.4M
$6.6M
Q1 25
$91.3M
$11.7M
Q4 24
$57.3M
$18.3M
Q3 24
$58.9M
Q2 24
$76.2M
Q1 24
$83.8M
Total Debt
FBIO
FBIO
FLD
FLD
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
FLD
FLD
Q4 25
$49.9M
$63.0M
Q3 25
$55.9M
$94.7M
Q2 25
$43.9M
$88.5M
Q1 25
$22.3M
$71.9M
Q4 24
$22.7M
$-67.8M
Q3 24
$21.2M
$-7.4M
Q2 24
$17.9M
$-74.0M
Q1 24
$23.0M
$-9.4M
Total Assets
FBIO
FBIO
FLD
FLD
Q4 25
$185.5M
$153.5M
Q3 25
$181.4M
$191.0M
Q2 25
$159.9M
$182.1M
Q1 25
$178.1M
$148.5M
Q4 24
$144.2M
$125.7M
Q3 24
$127.1M
$52.2M
Q2 24
$145.7M
$51.8M
Q1 24
$164.6M
$51.5M
Debt / Equity
FBIO
FBIO
FLD
FLD
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
FLD
FLD
Operating Cash FlowLast quarter
$-12.5M
$-16.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
FLD
FLD
Q4 25
$-12.5M
$-16.1M
Q3 25
$-6.1M
$-2.5M
Q2 25
$-27.6M
$-4.0M
Q1 25
$-19.6M
$-5.0M
Q4 24
$-12.9M
$-3.3M
Q3 24
$-20.1M
$-2.2M
Q2 24
$-21.8M
$-859.6K
Q1 24
$-25.4M
$-354.2K
Capex Intensity
FBIO
FBIO
FLD
FLD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
Q1 24
Cash Conversion
FBIO
FBIO
FLD
FLD
Q4 25
Q3 25
-1.04×
-4.47×
Q2 25
-1.78×
-0.30×
Q1 25
Q4 24
-6.82×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FBIO
FBIO

Segment breakdown not available.

FLD
FLD

Banking And Payment Revenues$8.4M92%
Other$706.0K8%

Related Comparisons